We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




Rapid Bacterial Infection Test Differentiates Between MRSA and MSSA in 53 Minutes

By LabMedica International staff writers
Posted on 18 Jul 2023
Print article
Image: The Vivalytic MRSA/MSSA Rapid Test provides a quick diagnosis of methicillin resistance at the point of care (Photo courtesy of Randox)
Image: The Vivalytic MRSA/MSSA Rapid Test provides a quick diagnosis of methicillin resistance at the point of care (Photo courtesy of Randox)

Methicillin-resistant Staphylococcus aureus (MRSA) is a critical pathogen responsible for numerous hospital-acquired infections, leading to complications and increased mortality rates. The World Health Organization has estimated that patients infected with MRSA experience a mortality rate approximately 50% higher than those affected by non-resistant strains of Staphylococcus aureus. Therefore, swiftly and accurately determining whether the bacterial strain is methicillin-sensitive (MSSA) or resistant is crucial, particularly in emergency situations. Conducting MRSA/SA screening plays a significant role in mitigating health risks by curtailing contamination, breaking the chain of infection, and combating superbugs and antimicrobial resistance. Now, a rapid test provides differentiation between MRSA and MSSA in 53 minutes at the point of care.

The Vivalytic MRSA/MSSA Rapid Test from Randox Laboratories (Crumlin, UK) is a qualitative RT-PCR diagnostic test capable of identifying and distinguishing MRSA, MSSA, and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). Using a single cartridge, the Vivalytic MRSA/MSSA test facilitates a speedy diagnosis of MRSA infections, allowing for the immediate application of suitable antibiotic treatment and prevention of complications. In contrast to the 1-3 days required for traditional culture sampling, the Vivalytic test provides reliable results in less than an hour right at the point of care, making it highly applicable for use in emergency departments.

The Vivalytic analyzer has been designed to be user-friendly, delivering speedy analyses and ease of handling. The patient-to-result process comprises a simple four-step procedure. The test commences when the user scans or inputs sample information and then scans the cartridge code into the integrated Vivalytic software. The sample is then added into the cartridge slot, after which the lid is closed, and the cartridge is inserted into the Vivalytic. The touchscreen display provides a countdown to the completion of the test, and results are shown on the screen. Furthermore, multiple Vivalytic devices can be wirelessly linked, enabling simultaneous control of multiple tests, all reporting to a primary Vivalytic platform.

Related Links:
Randox Laboratories 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: Color-enhanced scanning electron micrograph showing Salmonella Typhimurium (red) invading cultured human cells (Photo courtesy of Rocky Mountain Laboratories, NIAID, NIH)

AI Identifies Drug-Resistant Typhoid-Like Infection from Microscopy Images within Hours

Antimicrobial resistance is becoming a serious global health concern, making many infections increasingly difficult to treat and limiting available treatment options. This escalation in resistance raises... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.